Results of a Phase 1 clinical trial of RTA 402 in patients with advanced cancers was selected for an oral presentation at the 2008 annual meeting of the American Society of Clinical Oncologists.

The presentation is scheduled for 8:15 a.m. on Sunday, June 1, 2008.  The abstract is now available on the ASCO web site:

http://www.abstract.asco.org/AbstView_55_35471.html

Updated data from the clinical trial will be presented.